CHA News Article

Medication Shortages Continue
FDA works to increase supply of key emergency medications

As previously reported in CHA News, Pfizer has reported shortages of key emergency medications, particularly atropine, dextrose and epinephrine. Over the last several days, recalls have been announced for sodium bicarbonate manufactured by Hospira as well as succinylcholine and potassium phosphate manufactured by Pfizer. The Food and Drug Administration (FDA) is working to alleviate the shortages, in part by allowing vetted Australian drugmaker Phebra to export vials of sodium bicarbonate to the U.S. In addition, the FDA has published a list of drugs that may be used beyond their labeled expiration dates. The FDA has stated that it will continue to develop additional supply sources, to be posted on its website as they are secured. Pfizer and the other sodium bicarbonate manufacturer, Amphastar Pharmaceuticals, expect to restock supplies by mid-August, according to the American Society of Health-System Pharmacists. CHA will continue to monitor the situation and encourages members to direct questions to BJ Bartleson, vice president, nursing and clinical services, at or (916) 552-7537.